Cantor Fitzgerald Predicts TVTX FY2026 Earnings
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Travere Therapeutics in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal expects that the company will earn $1.86 per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on the stock. […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Travere Therapeutics in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal expects that the company will earn $1.86 per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on the stock. […]
